Completed NA INTERVENTIONAL 2-arm NCT01418703

Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus (MDB003)

Feasibility Study of a Modular Control to Range System in T1DM

Sponsor: Abbott Diabetes Care

Interventions Closed Loop Control (CLC) Open Loop

Updated 8 times since 2017 Last updated: Nov 9, 2014 Started: Oct 31, 2009 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Type 1 Diabetes Mellitus and is currently completed. Abbott Diabetes Care leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Diabetes Care
DexCom, Inc.
Insulet Corporation
University of California, Santa Barbara
University of Virginia

Data source: University of Virginia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charlottesville, United States